USANA Health Sciences Inc

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Market Capitalization 393.208 M
Employee 1 700
Founded 1992
CEO Jim Brown
Website www.usana.com
Headquarter Utah, United States
FIGI BBG000BX28M0
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

393.21 M Market capitalization

Price to earnings ratio

31.43

Price to sales ratio

0.57

Dividends per share

—

Dividend yield %

—

Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.

USNA

Financials

USANA Health Sciences Inc

Nachrichten

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y

ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth

Usana Health Sciences: Chief legal officer Foukas sells $95k in shares

USNA or UTHR: Which Is the Better Value Stock Right Now?

Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?

USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript

USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates

USANA Health Sciences: EPS übertrifft Schätzungen um 0,20 $ - Umsatz besser als erwartet

USANA Health Sciences earnings beat by $0.20, revenue topped estimates

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release